Answer
Immunosuppressive therapy including azathioprine increases the risk of lymphoproliferative disorders, skin cancers (melanoma and non-melanoma), sarcomas (Kaposi’s and non-Kaposi’s), and uterine cervical cancer in situ, with risk appearing related to the degree and duration of immunosuppression.
Sources for this answer
- Azathioprine 50mg Film-Coated TabletsTillomed Laboratories Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 9Document updated
Sources checked